These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2095798)

  • 21. Chitosan matrix for oral sustained delivery of ampicillin.
    Chandy T; Sharma CP
    Biomaterials; 1993 Oct; 14(12):939-44. PubMed ID: 8268386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential aspects of chitosan as pharmaceutical excipient.
    Ray SD
    Acta Pol Pharm; 2011; 68(5):619-22. PubMed ID: 21928704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of iron-crosslinked chitosan succinate and iron-crosslinked hydroxamated chitosan succinate and their in vitro evaluation as potential matrix materials for oral theophylline sustained-release beads.
    Aiedeh K; Taha MO
    Eur J Pharm Sci; 2001 May; 13(2):159-68. PubMed ID: 11297900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The formation and permeability of drugs across free pectin and chitosan films prepared by a spraying method.
    Hiorth M; Tho I; Sande SA
    Eur J Pharm Biopharm; 2003 Sep; 56(2):175-81. PubMed ID: 12957630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the hematological effects of a sustained release chitosan formulation of pentoxifylline with a commercial formulation.
    Yamac K; Kaptan KM; Beyan C; Teksin ZS; Ağabeyoğlu IT; Gökgöz L
    Arzneimittelforschung; 2000 Sep; 50(9):827-31. PubMed ID: 11050700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An overview of carboxymethyl derivatives of chitosan: Their use as biomaterials and drug delivery systems.
    Fonseca-Santos B; Chorilli M
    Mater Sci Eng C Mater Biol Appl; 2017 Aug; 77():1349-1362. PubMed ID: 28532012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-acylated chitosan: hydrophobic matrices for controlled drug release.
    Le Tien C; Lacroix M; Ispas-Szabo P; Mateescu MA
    J Control Release; 2003 Nov; 93(1):1-13. PubMed ID: 14602417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of a prolonged release tablet of aspirin with chitosan.
    Kawashima Y; Lin SY; Kasai A; Handa T; Takenaka H
    Chem Pharm Bull (Tokyo); 1985 May; 33(5):2107-13. PubMed ID: 4053235
    [No Abstract]   [Full Text] [Related]  

  • 29. Chitosan: some pharmaceutical and biological aspects--an update.
    Singla AK; Chawla M
    J Pharm Pharmacol; 2001 Aug; 53(8):1047-67. PubMed ID: 11518015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the ninhydrin assay to measure the release of chitosan from oral solid dosage forms.
    Leane MM; Nankervis R; Smith A; Illum L
    Int J Pharm; 2004 Mar; 271(1-2):241-9. PubMed ID: 15129991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of interpolymer complex formation on bioadhesive property and drug release phenomenon of compressed tablet consisting of chitosan and sodium hyaluronate.
    Takayama K; Hirata M; Machida Y; Masada T; Sannan T; Nagai T
    Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):1993-7. PubMed ID: 2268902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The safety of chitosan as a pharmaceutical excipient.
    Baldrick P
    Regul Toxicol Pharmacol; 2010 Apr; 56(3):290-9. PubMed ID: 19788905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of chitosan for sustained-release preparations of water-soluble drugs.
    Sawayanagi Y; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1982 Nov; 30(11):4213-5. PubMed ID: 7165883
    [No Abstract]   [Full Text] [Related]  

  • 34. Chitosan: the hemostatic agent.
    Subar P; Klokkevold P
    Dentistry; 1992 Oct; 12(3):18-9, 22. PubMed ID: 1291274
    [No Abstract]   [Full Text] [Related]  

  • 35. Directly compressed tablets containing chitin or chitosan in addition to mannitol.
    Sawayanagl Y; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1982 Nov; 30(11):4216-8. PubMed ID: 6819894
    [No Abstract]   [Full Text] [Related]  

  • 36. Chitin and chitosan as direct compression excipients in pharmaceutical applications.
    Badwan AA; Rashid I; Omari MM; Darras FH
    Mar Drugs; 2015 Mar; 13(3):1519-47. PubMed ID: 25810109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacy, pharmaceutics and modern drug delivery.
    Higuchi T
    Am J Hosp Pharm; 1976 Aug; 33(8):795-800. PubMed ID: 949063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a sustained release dosage form for alpha-lipoic acid. I. Design and in vitro evaluation.
    Bernkop-Schnürch A; Schuhbauer H; Clausen AE; Hanel R
    Drug Dev Ind Pharm; 2004 Jan; 30(1):27-34. PubMed ID: 15000427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained release of indomethacin from chitosan granules.
    Hou WM; Miyazaki S; Takada M; Komai T
    Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):3986-92. PubMed ID: 4092298
    [No Abstract]   [Full Text] [Related]  

  • 40. [Oral treatment, some points to consider].
    Duquet N
    J Pharm Belg; 2010 Dec; (4):93-9. PubMed ID: 21294314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.